Nephros Inc.

3960 Broadway
New York
New York
10032
United States

Tel: 212-781-5113
Fax: 212-781-5166

Email: info@nephros.com

Show jobs for this employer

173 articles with Nephros Inc.

  • Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced results for the three months ended March 31, 2021.

  • Nephros , Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial results on Thursday, May 6, 2021 after market close and will host a conference call that same day at 4:30 PM ET.

  • - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the first quarter of 2021.

  • Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021,

  • Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the  Inaugural Emerging Growth Virtual Conference ,  presented by M-Vest LLC and Maxim Group LLC. 

  • Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter Full Year Revenue $8.6 million, Down 17% Against Prior Year

  • Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter and full year 2020 financial results on Monday, March 1, 2021 after market close and will host a conference call that same day at 4:30 PM ET

  • Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced the appointment of Wes Lobo as Chief Marketing Officer, reporting directly to Nephros Chief Executive Officer, Andy Astor.

  • Anticipates $2.3 Million Revenue in Fourth Quarter, $8.5 Million in Full-Year; Quarterly Revenue Grew 9% Sequentially Over Third Quarter; Full Year Revenue Declined 17%

  • Nephros, Inc. announces the granting of a patent that covers technology utilized in HDF2, and announces expanded heat disinfection product capabilities.

  • HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021 Nephros Granted Patent Covering Technology in HDF Assist Module Nephros Expands EndoPur® and S100 Filter Labels to Include Heat Disinfection

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will participate at the following investor conferences in November. Virtual Fall Investor Summit November 16, 2020 9:30 AM ET Webcast link:  https://www.webcaster4.com/Webcast/Page/2038/38365 htt

  • Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that Dan D’Agostino was appointed the company’s Chief Financial Officer, effective November 6, 2020.

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its third quarter 2020 financial results on Thursday, November 5, 2020 after market close and will host a conference call that same day at 4:30 PM ET, during which management will discuss the

  • Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a registered direct offering of 833,333 shares of common stock at a price to the public of $6.00 per share.  The offering is expected to close on or about Oc

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th – 16th, 2020.

  • Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended September 30, 2020. Net revenues for the quarter are expected to be $2.1 million, a sequential increase of approximately 34% compared to the prior quarter ended

  • Presentation on Tuesday, September 1 st at 10:20am ET by Nephros, Inc. , today announced that it will be presenting at the LD 500 virtual investor conference on Tuesday, September 1 st at 10:20am ET. Andy Astor, President and Chief Executive Officer of Nephros

  • Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that Andy Astor, currently the company’s Chief Operating Officer and Chief Financial Officer, has been named President and CEO, effective August

  • Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, announced financial results for the three months ended June 30, 2020.